［1］Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions\[J\]. Clin Gastroenterol, 2013, 42(2): 261-284.

［2］Rocken C, Warneke V. Molecular pathology of gastric cancer\[J\]. Pathologe, 2012, 33(Suppl 2): 235-240.

［3］Cervantes A, Rodriguez Braun E, Perez Fidalgo A, et al. Molecular biology of gastric cancer\[J\]. Clin Transl Oncol, 2007, 9(4): 208-215.

［4］Tam C, Wong JH, Tsui SK, et al. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years\[J\]. Appl Microbiol Biot, 2019, 103(12): 4649-4677.

［5］Fatima R, Akhade VS, Pal D, et al. Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets\[J\]. Mol Cell Ther, 2015, 3:5.

［6］Zhang Y, Li H, Zhang W, et al. LASSObased CoxPH model identifies an 11lncRNA signature for prognosis prediction in gastric cancer\[J\]. Mol Med Rep, 2018, 18(6): 5579-5593.

［7］Laehnemann D, Borkhardt A, McHardy AC. Denoising DNA deep sequencing datahighthroughput sequencing errors and their correction\[J\]. Brief Bioinform, 2016, 17(1):154-179.

［8］Song P, Wu L, Jiang B, et al. Agespecific effects on the prognosis after surgery for gastric cancer: A SEER populationbased analysis\[J\]. Oncotarget, 2016, 7(30): 48614-48624.

［9］Feng F, Liu J, Wang F, et al. Prognostic value of differentiation status in gastric cancer\[J\]. BMC Cancer, 2018, 18(1): 865-870.

［10］Pan Y, Chen H, Shen X, et al. Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma\[J\]. Clin Chim Acta, 2018, 480:199-205.

［11］GhafouriFard S, Taheri M. Long noncoding RNA signature in gastric cancer\[J\]. Exp Mol Pathol, 2019, 4(113): 104365.

［12］Luo Y, Yang J, Yu J, et al. Long noncoding RNAs: Emerging roles in the immunosuppressive tumor microenvironment\[J\]. Front Oncol, 2020, 10: 48.